Status:
COMPLETED
Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD
Lead Sponsor:
Karaganda Medical University
Conditions:
Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease Moderate
Eligibility:
All Genders
18-84 years
Phase:
PHASE4
Brief Summary
Recruitment of patients with COPD. Assessment of clinical status, determination of vitamin D and cathelicidin levels. In the group with vitamin D deficiency, patients receive cholecalciferol (vitamin ...
Detailed Description
Interventional prospective research design. The study will be conducted on patients with moderate and severe COPD. The material for the study will be the blood and sputum of patients with COPD. Rese...
Eligibility Criteria
Inclusion
- \- Clinically confirmed chronic obstructive pulmonary disease
Exclusion
- age under 18
- pregnancy
- mental disorders
- cancer
- terminal renal and hepatic insufficiency
Key Trial Info
Start Date :
February 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05431218
Start Date
February 18 2020
End Date
December 31 2021
Last Update
April 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karaganda Medical University
Karaganda, Kazakhstan, 100000